FHU-TRANSLAD: an innovative genome project for the benefit of patients and their families.
FHU-TRANSLAD is an innovative, ground-breaking genome project that is international in scope and organised with a view to helping patients and their families. Its purpose is to address issues which current organisations are individually unable to resolve, with respect to diagnosis and individual patient care. It was designed based on a patient needs analysis and organisational requirements occasioned by the emergence of innovative technologies. It facilitates the transition from research to care so that patients can more rapidly benefit from new technologies. It spurs the development of treatment strategies and helps disseminate knowledge to students, professionals and the wider public. FHU-TRANSLAD also highlights the social and economic issues surrounding genetics and personalised medicine and encourages public discussion on ethical questions raised by the admittance of these new technologies into healthcare systems.
FHU TRANSLAD certification
FHU-TRANSLAD was ranked n°1 in 2013 by an international panel following a call for proposals jointly launched by the university hospital healthcare and teaching institutions of the Bourgogne-Franche-Comté regions (Dijon and Besançon university hospitals, the universities of Bourgogne and Franche-Comté, the Georges-François Leclerc Cancer Care Centre and the French Blood Agency), with the aim of promoting innovative best-practice projects uniting people in a spirit of partnership.
FHU-TRANSLAD is structured around five areas of focus
- Area 1 : a centre for patient evaluation and multidisciplinary care
- Area 2 : the optimisation of genetic diagnosis
- Area 3 : an appropriate training and genomics information resource centre for hereditary diseases
- Area 4 : more efficient organisation of healthcare and ethical care in genomic medicine: input from the human and social sciences
- Area 5 : high-quality clinical, molecular, neurocognitive and pathophysiological research with a centre for clinical and therapeutic trials
A multidisciplinary team : geneticists, biologists, bioinformaticians, dermatologists, paediatricians, doctors of internal medicine, organ specialists, psychiatrists, psychologists specialising in cognition, health economists, philosophers and ethicists